Oct. 22 at 10:42 PM
$CURX There’s a lot of misinformation going on for this stock. Someone mentioned this is going back up to
$9.00. This stock has never been
$9.00. Its IPO was in August 2025 at
$4.00 per share. It’s down approximately
$3.34 since the IPO. Their drug for ulcerative colitis is being submitted to the FDA for the initial drug application sometime in 2026.